Discussing the role of drug therapy for chronic heart failure across the spectrum of EF and evolving treatment paradigms for instituting and titrating all drug classes.

Defining clinical inertia as barrier

Identifying the role of clinical trials in the development of new heart failure therapies: Goals of current and future trial design and endpoints

Reviewing and discussing best practices for worsening heart failure events, including acute treatment strategies to prevent re-hospitalization and improve natural history of disease.

Discussing restrictive cardiomyopathies and associated diagnostic, treatment strategies and clinical trials to improve clinical outcomes and disease trajectory.

Discussing the role of interventional and device management in acute heart failure and care trends in a contemporary intensive care setting.

Recognizing challenges at time of care transitions and address multidisciplinary strategies to improve care coordination (costs and access to new HF medications and follow-up care).

Describing how to initiate and sustain an open access and medication titration clinic.

Identifying advances in the management of patients with heart failure in the outpatient setting with utilization of ambulatory monitoring, wearable technologies, and electronic care systems.